Press Releases
BioScreening.net » Press Releases
- Prosolia, AB Sciex Obtain License for ORNL Analytical Technology
- Sucampo Presents New Phase III Data from Opioid-Induced Bowel Dysfunction Study
- GE Healthcare, Karolinska University Ally to Enable Routine Application of Cell Therapies
- CHDI, Lundbeck Partner for Preclinical Studies with Huntington Disease Candidate
- InterMune Sells Actimmune to Vidara for $55M
- Scientists Describe New Genetic Subtypes of Prostate Cancer
- MSC-Secreted Factor Key to Impact of Multiple Sclerosis Cell Therapy
- Marina, Girindus Ink Oligonucleotide Manufacturing, Supply Deal
- Ventana Licenses Gen-Probe IP for Measuring ERG Protein in Prostate Cancer
- BioDelivery Earns $2.5M from Meda on Pricing Approval of Breakyl in First EU Country
- Osiris Wins Race to Market a Stem Cell Product with Canadian Go-Ahead
- Google Search Engine Forms Basis of Algorithm to Identify Prognostic Cancer Biomarkers
- Janssen Reports Positive Phase III Data for Chronic Diabetic Peripheral Neuropathy Analgesic
- Ruga Licenses Selexagen’s RAF Kinase Program for Targeted Cancer Therapy
- Solvo, XenoBiotic to Provide In Vitro Transporter Services in the U.S.
- Affymetrix Launches Circulating Tumor Cell Platform in Deal with ScreenCell
- Alga Provides Feasible Mass Production System for Subunit Malaria Vaccine Candidate
- Agilent Acquires Cancer In Vitro Diagnostic Firm Dako for $2.2B in Cash
- Aveo, Astellas Report Positive Data from Phase III Comparative Tivozanib Trial in RCC
- Evotec Becomes First European CRO to Offer Agilent’s RapidFire Screening Tool
